The Chemical Structure For The Active Ingredient Neomycin Sulfate (Maxitrol Ointment 01)
Maxitrol Ointment
Product Images NDC 0078-0771
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Maxitrol (NDC 0078-0771). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
The Chemical Structure For The Active Ingredient Polymyxin B Sulfate (Maxitrol Ointment 02)
Polymyxin-text (Maxitrol Ointment 03)
DAB stands for diamincbutyric acid.*
The Chemical Structure For The Active Ingredient Dexamethasone (Maxitrol Ointment 04)
Ndc 0078-0771-01 Maxitrol® (neomycin And Polymyxin B Sulfates And Dexamethasone Ophthalmic Ointment) Sterile 3.5 G Net Wt. Rx Only Novartis (Maxitrol Ointment 05)
Maxitrol is an ophthalmic ointment manufactured by SA Alon-Couvreur NV in Belgium and distributed by Novartis Pharmaceuticals Corporation in East Hanover, NJ. The product contains neomycin and polymyxin B and has a net weight of 3.5g. The text also includes some numerical and letter codes, as well as some unreadable characters.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
